Patient info Open main menu

Clindamycin 150 mg capsules hard – patient leaflet, side effects, dosage

Last updated: · Text from the MHRA, as of · About this document

Medicine status: Prescription only (POM) Details

Medicine strength:
150 mg
Contains active substance:

Patient leaflet - Clindamycin 150 mg capsules hard

1. What Clindamycin Capsules are and what they are used for

Clindamycin Capsules contain clindamycin hydrochloride which is an antibiotic used in the treatment of serious bacterial infections.

2. What you need to know before you take Clindamycin Capsules

Do not take Clindamycin Capsules

  • if you are allergic (hypersensitive) to clindamycin, lincomycin or to any of the other ingredients in this medicine (listed in section 6).

Warnings and precautions

Talk to your doctor or pharmacist before taking Clindamycin Capsules

  • if you have diarrhoea or usually get diarrhoea when you take antibiotics or have ever suffered from problems with your stomach or intestines. If you develop severe or prolonged or bloody diarrhoea during or after using Clindamycin Capsules tell your doctor immediately since it may be necessary to interrupt the treatment. This may be a sign of bowel inflammation (pseudomembranous colitis) which can occur following treatment with antibiotics,
  • if you suffer from problems with your kidneys or liver,
  • if you suffer from asthma, eczema or hayfever,
  • if you develop any severe skin reactions or hypersensitivity to Clindamycin Capsules. Clindamycin does not get into the brain and is therefore not suitable for treating serious infections in and around the brain. Your doctor may need to give you another antibiotic if you have these infections.

Acute kidney disorders may occur. Please inform your doctor about any medication you currently take and if you have any existing problems with your kidneys. If you experience decreased urine output, fluid retention causing swelling in your legs, ankles or feet, shortness of breath, or nausea you should contact your doctor immediately.

Due to the risk of inflammation of the oesophagus (oesophagitis) and oesophageal ulcer, it is important to always take Clindamycin Capsules exactly as described in section 3.

Other medicines and Clindamycin Capsules

Tell your doctor, pharmacist or nurse if you are taking, have recently taken or might take any other medicines.

  • muscle relaxants used for operations

    (neuromuscular blockers),

  • oral contraceptive pills. You should use extra contraception such as condoms whilst taking Clindamycin Capsules and for seven days after taking Clindamycin Capsules,
  • warfarin or similar medicines - used to thin the blood. You may be more likely to have a bleed. Your doctor may need to take regular blood tests to check how well your blood can clot,
  • CYP3A4 or CYP3A5 inducers like rifampicin may impact effectiveness of the medicine.

Pregnancy and breast-feeding

Pregnancy

If you are pregnant or think you might be pregnant you should contact your doctor before taking Clindamycin Capsules .

Ask your doctor or pharmacist for advice before taking any medicine.

Breast-feeding

Tell your doctor if you will be breast-feeding while taking Clindamycin Capsules as clindamycin may be passed into breast milk. Your doctor will decide if Clindamycin Capsules are appropriate for you. Although it is not likely that a nursing infant will take in very much of the active substance from the milk it drinks, if your baby gets bloodstained diarrhoea or shows any signs of illness, tell your doctor at once. You should stop breast-feeding if this happens.

Driving and using machines

No effects on the ability to drive or use machines have been seen with Clindamycin Capsules.

Clindamycin Capsules contain lactose

If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before using this medicinal product.

3. How to take Clindamycin Capsules

Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor, pharmacist or nurse if you are not sure.

Clindamycin Capsules should always be swallowed whole with a full glass of water no less than 30 minutes before lying down, to avoid a possible irritation of the oesophagus.

Adults and Elderly Patients:

The recommended dose of Clindamycin 150 mg Capsules is between 150 and 450 mg (1 to 3 capsules) every 6 hours, depending on the severity of your infection.

The recommended dose of Clindamycin 300 mg Capsules is 300 mg (1 capsule) every 6 hours.

Use in Children

This medicine is used for children who are able to swallow capsules. The recommended dose in children is between 12 and 25 mg/kg/day of bodyweight, divided into six hourly doses, depending on the severity of the infection. Clindamycin should be dosed based on total body weight regardless of obesity. Your doctor will work out the number of capsules that your child should have. If your child is unable to swallow capsules, talk to your doctor or pharmacist.

Long term use of Clindamycin Capsules

If you have to take Clindamycin Capsules for a long time, your doctor may arrange regular liver, kidney and blood tests. Do not miss these check-ups with your doctor.

Long term use can also make you more likely to get other infections that do not respond to Clindamycin Capsules treatment.

If you take more Clindamycin Capsules than you should

If you accidentally take too many Clindamycin Capsules contact your doctor at once or go to the nearest hospital casualty department. Always take the labelled medicine package with you, whether there are any Clindamycin Capsules left or not. Do not take any more capsules until your doctor tells you to.

If you forget to take Clindamycin Capsules

If the forgotten dose is just a few hours late, use it straight away. If it is nearly time for your next dose miss out the forgotten one. Do not take a double dose to make up for a missed dose.

If you stop taking Clindamycin Capsules

If you stop taking Clindamycin Capsules too soon your infection may come back again or get worse. Do not stop taking Clindamycin Capsules unless your doctor tells you to.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Tell your doctor immediately if you develop:

  • severe, persistent or bloody diarrhoea (which may be associated with stomach pain or fever). This is an uncommon side effect which may occur during or after completing treatment with antibiotics and can be a sign of serious bowel inflammation or pseudomembranous colitis,
  • signs of a severe allergic reaction such as sudden wheeziness, difficulty in breathing, dizziness, swelling of eyelids or face or lips or throat or tongue, rash or itching (especially affecting the whole body),
  • chest pain in the context of allergic reactions, which may be a symptom of allergy triggered cardiac infarction (Kounis syndrome) (frequency not known [cannot be estimated from the available data]),
  • blistering and peeling of large areas of skin, fever, cough, feeling unwell and swelling of the gums, tongue or lips,
  • yellowing of the skin and whites of the eyes (jaundice),
  • potentially life threatening skin rashes:

    ° a widespread rash with blistering and peeling of large areas of skin, particularly around the mouth, nose, eyes or genitals, known as Stevens-Johnson syndrome, or a more severe form with extensive peeling of the skin (more than 30% of the body surface) known as toxic epidermal necrolysis, ° a rare skin eruption that is characterised by the rapid appearance of areas of red skin studded with small pustules (small blisters filled with white/ yellow fluid) (Acute Generalised Exanthematous Pustulosis (AGEP),

    ° skin rash, which may blister, and looks like small targets (central dark spots surrounded by a paler area, with a dark ring around the edge - erythema multiforme),

    ° widespread red skin rash with small pus-containing blisters (bullous exfoliative dermatitis), 410mm

° fever, swollen lymph nodes or skin rash, these may

be symptoms of a condition known as DRESS (Drug reaction with eosinophilia and systemic symptoms) and can be severe and life-threatening,

  • fluid retention causing swelling in your legs, ankles or feet, shortness of breath or nausea.

Other possible side effects may include:

Common (may affect up to 1 in 10 people):

  • abnormal liver function tests (poor liver function),
  • pain in the stomach/abdomen, diarrhoea.

Uncommon (may affect up to 1 in 100 people):

  • feeling sick or being sick,
  • rash - characterised by a flat red area on the skin that is covered with small bumps, hives.

Not Known (Frequency cannot be estimated from the available data):

  • infection inside and around the vagina,
  • inflammation of the large intestine which causes abdominal pain, fever or diarrhoea due to infection by Clostridioides difficile,
  • effects on your blood system: reduced numbers of blood cells which may cause bruising or bleeding or weaken the immune system,
  • changes in the way things taste,
  • inflammation of the lining of the oesophagus (gullet), including severe damage to the food pipe (necrotising oesophagitis), open sores or lesions in the lining of the oesophagus (gullet),*
  • yellowing of the skin and whites of the eyes (jaundice),
  • red or scaly skin (exfoliative dermatitis), red measles-like rash (rash morbilliform), itching,
  • inflammation of blood vessels in the skin (cutaneous vasculitis),
  • skin reaction characterised by symmetrical, sharply defined redness in the skin folds, particularly the buttocks, groin, and armpits (symmetrical drug-related intertriginous and flexural exanthema). * Side effects that are more likely to occur if Clindamycin Capsules are taken in a lying position and/or without enough water.

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.

5. How to store Clindamycin Capsules

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the blister and carton after ‘EXP’. The expiry date refers to the last day of that month.

Do not store above 30°C.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

6. Contents of the pack and other information

What Clindamycin Capsules contain

The active substance is clindamycin hydrochloride. Each capsule contains clindamycin hydrochloride equivalent to 150 mg or 300 mg of clindamycin.

The other ingredients are: lactose monohydrate, maize starch, talc and magnesium stearate.

Capsule shell (150 mg): gelatin and titanium dioxide (E171).

Capsule shell (300 mg): gelatin, brilliant blue FCF (E133), carmoisine (E122) and titanium dioxide (E171).

Printing ink (150 mg and 300 mg): shellac, black iron oxide (E172) and propylene glycol (E1520).

What Clindamycin Capsules look like and contents of the pack

Clindamycin 150 mg Capsules are size ‘1’ hard gelatin capsules with a white colour body and cap containing a white to off-white powder. The capsules are imprinted with ‘I 62’ on the cap.

Clindamycin 300 mg Capsules are size ‘0’ hard gelatin capsules with a purple colour body and cap containing white to off-white powder. The capsules are imprinted with ‘I 63’ on the cap.

Clindamycin Capsules are available in packs of 7, 10, 14, 15, 20, 24, 28, 30, 56, 60, 84, 90, 100, 112 and 120.

Not all pack sizes may be marketed.

Marketing Authorisation Holder

Morningside Healthcare Ltd.

Unit C, Harcourt Way

Leicester, LE19 1WP, UK

Manufacturer

Morningside Pharmaceuticals Ltd.

5 Pavilion Way

Loughborough

LE11 5GW, UK

Morningside Pharmaceuticals Ltd. &

Aspire Pharma Ltd.

Second Floor, Boss Court

7 Barton Close, Grove Park

Leicester, LE19 1SJ, UK

Aspire Pharma Ltd.

Unit 4, Rotherbrook Court

Bedford Road, Petersfield

GU32 3QG, UK

This leaflet was last revised in August 2026.

MPL16515

MPL16522

MPL16539 - P2.1 PP000856 410mm

Size: 20, 30 and 100 capsules PL/PA no: PL 20117/0282-283 Type: Leaflet

Reason for request: Type IB Variation

Version no: 2.1

Date of revision: 14.8.26

Colours: As swatches

Font(s): Nimbus Sans L 9pt

A/W software: Indesign CC

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 20117/0282

Last revision stated in the text: 14 August 2026 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Clindamycin 150 mg capsules hard

Prescription needed? Yes, prescription-only medicine (POM)
Active substance Clindamycin
Strength 150 mg
Pharmaceutical form Oral capsule
Green transparent (body) / Light blue opaque (Cap), size '2' hard gelatin capsule printed with 'M' on cap and '41' on body filled with white to off-white granular powder. Approximately 18 mm in length.
How is it taken Oral
Excipients Lactose monohydrate, Maize starch, Talc, Magnesium stearate, Gelatin, FD&C Blue 1(E133), Titanium dioxide (E171), D&C Yellow 10 (E104), Shellac, Potassium hydroxide
Pack sizes 24 capsule, 100 capsule
Is it available? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Shelf life Blister: 36 months
Storage Do not store above 25°C.
Drug group (ATC) Lincosamide antibiotics
  1. J Antiinfectives for systemic use
    1. J01 Antibacterials for systemic use
      1. J01F Macrolides, lincosamides and streptogramins
        1. J01FF Lincosamides
          1. J01FF01 clindamycin
Marketing authorisation PL 20117/0282, PL 25298/0065 (first authorised 4 February 2025)
Marketing authorisation holder Brown & Burk UK Limited
Codes GTIN 5055132716515, 5055132716522, 5060124641041, 5060124641058 · BNF 05010600

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.1.0 of 12 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.